Sano Genetics

Accelerating the world's transition to precision medicine.

Founded 2016

Cambridge, United Kingdom 50 employees Total: $20.86M Biopharma, Biotechnology +2

General Information

Company Name Sano Genetics

Founded Year 2016

Location

Cambridge, United Kingdom

Employees 50

Industries Biopharma, Biotechnology, Health Care +1

Business Model B2B, Platform, B2B2C

Revenue Model Service Fee, Project Based, Usage Based

Offices as of Oct 2026

Cambridge, United Kingdom

Social

BounceWatch is an independent company data service, not affiliated with Sano Genetics. To contact Sano Genetics, visit sanogenetics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Sano Genetics compare?

A PDF of Sano Genetics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Sano Genetics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Event Participation Oct 01, 2026

Sano Genetics is hosting Episode 259 of The Genetics Podcast, featuring Jenny Hsieh, President of the Danon Foundation, to discuss Danon disease.

Homepage Update

Significant changes detected on company website (44.5% content change).

New Partnership Sep 29, 2026

The company Sano Genetics has partnered with PKB to make trial recruitment faster and more patient-led, with the first project supporting a Parkinson's trial.

Get alerts when Sano Genetics shows new signals

About Sano Genetics

Sano Genetics, founded in 2016, is positioned at the cutting edge of the Biopharma and Life Sciences industries. Headquartered in the United Kingdom, the company aims to revolutionize health care by "accelerating the world's transition to precision medicine." Their innovative platform combines genetic testing, recruitment, and long-term engagement to streamline operations for precision medicine teams.

Sano Genetics' multi-functional approach not only accelerates patient enrollment but also simplifies complex processes, ultimately driving breakthroughs in patient care. Their recent investment from PharmStars, as of 01 July 2024, underscores investor confidence in their mission and potential. With a focus on biotechnology and health care, Sano Genetics is well-positioned to impact the future of medicine substantially by supporting the growing demand for personalized treatment solutions.

Business keywords: Precision Medicine, Genetic Testing, Health Technology, Personalized Medicine, Research Studies, Genetic Data Contribution, Medical Research, Patient Engagement, Data-Driven Healthcare, Clinical Trials, Genomics, Health Data Analytics, Patient Recruitment, Scientific Research

Services & Products

Recruitment support

Protocol development

DNA testing

Electronic medical record retrieval

Patient engagement

Prescreening and digital consent

Target Customers

Life science companies Research initiatives Sponsors Contract Research Organizations (CROs) Research sites

Pricing

as listed on Sep 28, 2026

On request

Sano Genetics's pricing page

Funding Rounds & Investors (11)

View All

Funding Stage	Amount	Investors	Lead Investors	Date
Round	Undisclosed	1	PharmStars	01 Jul 2024
Early VC	£8.97M	1	Plural	01 Jan 2024
Grant	£330.00K	-		01 Aug 2023
Series A	£8.30M	10	Episode 1 Ventures, MMC Ventures +8	01 Feb 2022
Early VC	£2.50M	4	Episode 1 Ventures, January Ventures +2	01 Jan 2021
Support Program	Undisclosed	1	Google	01 Jan 2020
Seed	£500.00K	5	Seedcamp, Cambridge Enterprise +3	01 Apr 2019
Support Program	Undisclosed	1	KQ Labs	01 Jan 2019
Seed	£250.00K	1	Seedcamp	01 May 2018
Grant	£10.00K	1	Cambridge University Entrepreneurs	01 May 2017

View All 11 Funding Rounds

Latest News

View All

Brunch with Plural and HelixNano’s Carina Namih: I needed to go to Silicon Valley to find VCs who co... — Sifted

Brunch with Plural and HelixNano’s Carina Namih: I needed to go to Silicon Valley to find VCs who could ‘match my ambition’

Sifted Apr 26, 2024

Early-stage UK VC Episode 1 closes $95M third fund

Techcrunch Feb 07, 2024

Founder-led deep tech investor Plural launches €400M fund

Thenextweb Jan 23, 2024

Sano Genetics raises $11.4M to advance precision medicine clinical trials

Tech Jan 23, 2024

Plural launches a new €400M fund to back world-changing startups

Tech Jan 23, 2024

Founders of Wise and Skype raise $436 million to build tech giants in Europe

Cnbc Jan 23, 2024

Sano Genetics Alternatives & Competitors

View All Alternatives

Sano Genetics vs

DxTerity United States

Bringing the power of precision medicine to autoimmune disease

Venture round

31 employees

Biotechnology, Health Care

Compare Sano Genetics vs DxTerity

Sano Genetics vs

InformedDNA United States

The leading applied genomics solutions company in the U.S.

Debt Financing

99 employees

Biotechnology, Health Care

Compare Sano Genetics vs InformedDNA

Sano Genetics vs

LCM Genect Italy

Enable precision medicine

6 employees

Biopharma, Biotechnology

View all alternatives

FAQ About Sano Genetics

Accelerating the world's transition to precision medicine.

Sano Genetics was founded in 2016.

Sano Genetics is headquartered in Cambridge, United Kingdom.

Sano Genetics operates in Biopharma, Biotechnology, Health Care and Life Sciences. Its work centres on Precision Medicine, Genetic Testing, Health Technology and Personalized Medicine. Its customers include Life science companies, Research initiatives and Sponsors.

Sano Genetics has a B2B, Platform and B2B2C business model. Its revenue comes from Service Fee, Project Based and Usage Based.

As listed on Sano Genetics's pricing page on Sep 28, 2026: On request.

Sano Genetics has approximately 50 employees.

Sano Genetics has completed 11 funding rounds, raising a total of $20.86M.

Sano Genetics offers: Recruitment support, Protocol development, DNA testing, Electronic medical record retrieval, Patient engagement, Prescreening and digital consent.

Top alternatives and competitors to Sano Genetics include DxTerity, InformedDNA, LCM Genect, CENTOGENE, Aniling. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Sano Genetics and DxTerity are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Sano Genetics, https://bouncewatch.com/company/sano-genetics, updated 30 August 2026. When citing, please name BounceWatch and link this page.

Sano Genetics

General Information

Discover More

What changed at Sano Genetics recently?

About Sano Genetics

Services & Products

Target Customers

Pricing

Funding Rounds & Investors (11)

Latest News

Sano Genetics Alternatives & Competitors

FAQ About Sano Genetics